Auron Therapeutics website screenshot

Auron Therapeutics

Auron Therapeutics is a clinical-stage biotechnology company headquartered in Newton, Massachusetts, developing therapies that target cell-state plasticity to address the underlying causes of disease across oncology and inflammatory disease indications. The company built the AURIGIN platform, which integrates multi-omic profiling and computational biology to map how cells change states and identify those states that can be therapeutically targeted. Auron was founded by Dr. Katharine Yen with co-founders Dr. Ross Levine, Dr. Eytan Stein, and Dr. Matthew Vander Heiden, a team drawing on experience from Agios Pharmaceuticals and its FDA-approved IDH inhibitor programs. It is backed by investors including Apollo, Arkin Bio, Casdin Capital, and DCVC Bio. As a therapeutics company Auron publishes no public developer API, documentation, or developer portal; this profile captures its corporate and legal web presence only.

Auron Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Oncology, and Drug Discovery.

🌐 Visit website 📡 Source on GitHub
13.9/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiotechnologyPharmaceuticalsOncologyDrug DiscoveryComputational BiologyLife SciencesMulti-omics

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 13.9/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 4.2 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/auron-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Auron Therapeutics Domain Security

TLSv1.3 · HSTS

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy
 TermsOfService
TermsOfService

Company 3

The organization behind the API

Website
Website
 About
About
 LinkedIn
LinkedIn

Source (apis.yml)

apis.yml Raw ↑ 
aid: auron-therapeutics
name: Auron Therapeutics
description: Auron Therapeutics is a clinical-stage biotechnology company headquartered in Newton, Massachusetts, developing
  therapies that target cell-state plasticity to address the underlying causes of disease across oncology and inflammatory
  disease indications. The company built the AURIGIN platform, which integrates multi-omic profiling and computational biology
  to map how cells change states and identify those states that can be therapeutically targeted. Auron was founded by Dr.
  Katharine Yen with co-founders Dr. Ross Levine, Dr. Eytan Stein, and Dr. Matthew Vander Heiden, a team drawing on experience
  from Agios Pharmaceuticals and its FDA-approved IDH inhibitor programs. It is backed by investors including Apollo, Arkin
  Bio, Casdin Capital, and DCVC Bio. As a therapeutics company Auron publishes no public developer API, documentation, or
  developer portal; this profile captures its corporate and legal web presence only.
url: https://raw.githubusercontent.com/api-evangelist/auron-therapeutics/refs/heads/main/apis.yml
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://www.aurontx.com/favicon.ico
x-type: company
x-source: vc-portfolio
x-backed-by:
- dcvc
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Oncology
- Drug Discovery
- Computational Biology
- Life Sciences
- Multi-omics
apis: []
common:
- type: DomainSecurity
  url: security/auron-therapeutics-domain-security.yml
- type: Website
  url: https://www.aurontx.com
- type: About
  url: https://www.aurontx.com/about
- type: PrivacyPolicy
  url: https://www.aurontx.com/legal/privacy-policy
- type: TermsOfService
  url: https://www.aurontx.com/legal/terms-of-use
- type: LinkedIn
  url: https://www.linkedin.com/company/auron-therapeutics/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence